Disease Registry based approaches to determining molecular risk factors for glaucoma blindness, and applying them in clinical practice

这位执业研究员从澳大利亚、新西兰和现在的国际上收集了大量因青光眼和糖尿病并发症而失明的患者，以确定导致视力下降的因素。他已经成功地确定了这些疾病的主要临床和遗传风险因素，现在正在将这些知识应用于疾病早期阶段的患者，以便更早和更积极地治疗高危患者，从而改善结果。

The Practitioner-Fellow has drawn together very large cohorts of patients from Australia, New Zealand and now internationally who have lost vision from Glaucoma and complications of Diabetes to determine the contributing factors. He has successfully identified major clinical and genetic risk factors for these diseases, and is now applying the knowledge to patients in early stages of disease, so that earlier and more aggressive treatment high risk individuals can lead to improved outcomes.